Prometheus Helidac
Executive Summary
San Diego-based Prometheus acquires Procter & Gamble's H. pylori triple therapy (bismuth subsalicylate/metronidazole/tetracycline)
You may also be interested in...
Procter & Gamble Recants: Size Does Matter In Rx Industry
Procter & Gamble is giving serious consideration to taking a major step into the pharmaceutical acquisition field.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011